Annals of Oncology

News:

First European judgement on passive smoking
Ann Oncol 11: 767.
[PDF] [Request Permissions]

National plan for palliative care launched in Spain
Ann Oncol 11: 767.
[PDF] [Request Permissions]

President Mbeki fuels AIDS furore
Ann Oncol 11: 767-768.
[PDF] [Request Permissions]

Gore on genetic testing and clinical trials
Ann Oncol 11: 768.
[PDF] [Request Permissions]

Toms River, New Jersey: Is Ciba-Geigy responsible for the high rate of childhood cancers?
Ann Oncol 11: 768-769.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 769-772.
[PDF] [Request Permissions]

Editorial:

C. Monnerat and T. Le Chevalier

Chemotherapy for non-small-cell lung carcinoma, a look at the past decade
Ann Oncol 11: 773-776.
[PDF] [Request Permissions]

Reviews:

G. Tortora and F. Ciardiello

Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
Ann Oncol 11: 777-783.
[PDF] [Request Permissions]

J.-C. Goeminne, T. Guillaume, and M. Symann

Pitfalls in the detection of disseminated non-hematological tumor cells
Ann Oncol 11: 785-792.
[Abstract] [PDF] [Request Permissions]

Original articles:

T. Gamucci, R. Paridaens, B. Heinrich, J. H. Schellens, N. Pavlidis, J. Verweij, C. Sessa, S. Kaye, M. Roelvink, J. Wanders, and A. Hanauske

Activity and toxicity of GI147211 in breast, colorectal and non-small-cell lung cancer patients: An EORTC—ECSG phase II clinical study
Ann Oncol 11: 793-797.
[Abstract] [PDF] [Request Permissions]

P. Kosmidis, N. Mylonakis, D. Skarlos, E. Samantas, M. Dimopoulos, C. Papadimitriou, C. Kalophonos, N. Pavlidis, C. Nikolaidis, C. Papaconstantinou, G. Fountzilas, and Hellenic Cooperative Oncology Group (HeCOG)

Paclitaxel (175 mg/m²) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m²) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial
Ann Oncol 11: 799-805.
[Abstract] [PDF] [Request Permissions]

A. Alexanian and V. Torri

Survey on the treatment of non-small-cell lung cancer in Italy
Ann Oncol 11: 807-813.
[Abstract] [PDF] [Request Permissions]

H. Hatanaka, Y. Abe, T. Kamiya, F. Morino, J. Nagata, T. Tokunaga, Y. Oshika, H. Suemizu, H. Kijima, T. Tsuchida, H. Yamazaki, H. Inoue, M. Nakamura, and Y. Ueyama

Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer
Ann Oncol 11: 815-819.
[Abstract] [PDF] [Request Permissions]

T. De Pas, F. de Braud, R. Danesi, C. Sessa, C. Catania, G. Curigliano, S. Fogli, M. del Tacca, G. Zampino, A. Sbanotto, A. Rocca, S. Cinieri, E. Marrocco, A. Milani, and A. Goldhirsch

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer
Ann Oncol 11: 821-827.
[Abstract] [PDF] [Request Permissions]

M. Sorensen, P. B. Jensen, J. Herrstedt, F. R. Hirsch, and H. H. Hansen

A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer
Ann Oncol 11: 829-835.
[Abstract] [PDF] [Request Permissions]

E. Mari, I. Floriani, A. Tinazzi, A. Buda, M. Belfiglio, M. Valentini, S. Cascinu, S. Barni, R. Labianca, and V. Torri

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials: A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)
Ann Oncol 11: 837-835.
[Abstract] [PDF] [Request Permissions]

L. Specht, S. Kornum Larsen, and H. Sand Hansen

Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck
Ann Oncol 11: 845-849.
[Abstract] [PDF] [Request Permissions]

R. Sylvester and C. Sternberg

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why
Ann Oncol 11: 851-856.
[Abstract] [PDF] [Request Permissions]

J. Shamash, J. Walewski, J. Apostolidis, A. M. Wilson, J. M. Foran, R. K. Gupta, A. Z. S. Rohatiner, S. M. Kelsey, and T. A. Lister

Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma
Ann Oncol 11: 857-860.
[Abstract] [PDF] [Request Permissions]

C. R. Crawley, J. M. Foran, R. K. Gupta, A. Z. S. Rohatiner, K. Summers, J. Matthews, I. N. M. Micallef, J. A. Radford, S. A. Johnson, P. W. Johnson, J. W. Sweetenham, and T. A. Lister

A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma
Ann Oncol 11: 861-865.
[Abstract] [PDF] [Request Permissions]

E. Ortu La Barbera, P. Chiusolo, L. Laurenti, G. Menichella, A. L. Di Febo, N. Piccirillo, F. Sorà, R. Marra, L. Teofili, G. Leone, and S. Sica

MiCMA: An alternative treatment for refractory or recurrent Hodgkin's disease
Ann Oncol 11: 867-871.
[Abstract] [PDF] [Request Permissions]

C. Nicolaides, M. A. Dimopoulos, E. Samantas, D. Bafaloukos, C. Kalofonos, G. Fountzilas, E. Razi, P. Kosmidis, and N. Pavlidis

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
Ann Oncol 11: 873-875.
[Abstract] [PDF] [Request Permissions]

G. Theyer, E. Ulsperger, G. Baumgartner, M. Raderer, and G. Hamilton

Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients
Ann Oncol 11: 877-881.
[Abstract] [PDF] [Request Permissions]

F. X. Parnis, I. N. Olver, D. Kotasek, J. Norman, A. Taylor, J. Russell, K. Patterson, D. Keefe, and T. Marafioti

Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site
Ann Oncol 11: 883-884.
[PDF] [Request Permissions]

Clinical cases:

R. Zuha, T. Price, R. Powles, and J. Treleaven

Paradoxical emboli after central venous catheter removal
Ann Oncol 11: 885-886.
[Abstract] [PDF] [Request Permissions]

S. Srinivas and G. Varadhachary

Spontaneous pneumothorax in malignancy: A case report and review of the literature
Ann Oncol 11: 887-889.
[Abstract] [PDF] [Request Permissions]

D. ten Bokkel Huinink, G. A. M. Veltman, T. W. J. Huizinga, F. Roelfsema, and H. J. Keizer

Diabetes insipidus in metastatic cancer: Two case reports with review of the literature
Ann Oncol 11: 891-895.
[PDF] [Request Permissions]

Short report:

A. M. Hernandez, S. D. Fosså, A. Brøgger, A. Kat, and E. Skovlund

Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours
Ann Oncol 11: 897-898.
[PDF] [Request Permissions]

Letters to the editor:

E. Briasoulis, V. Karavasilis, and N. Pavlidis

Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions
Ann Oncol 11: 899.
[PDF] [Request Permissions]

S. Trippoli, M. Vaiani, F. Cattel, and A. Messori

Cost-effectiveness of irinotecan in advanced colorectal cancer
Ann Oncol 11: 899-900.
[PDF] [Request Permissions]

Book reviews:

C. Monnerat

Book review
Ann Oncol 11: 900.
[PDF] [Request Permissions]

E. L. Jones

Book review
Ann Oncol 11: 901.
[PDF] [Request Permissions]

C. Ripamonti

Book review
Ann Oncol 11: 902.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.